Managed by the U.S. Medical and Scientific Affairs (MSA) Tissue Diagnostics team.
Content available on this channel is for health care professional education only and not for promotional purposes.
For additional questions, please reach out to your local/regional medical and scientific affairs contact or email us at [email protected].
Content available on this channel is for health care professional education only and not for promotional purposes.
For additional questions, please reach out to your local/regional medical and scientific affairs contact or email us at [email protected].
-
0 likes 125 playsDr. Dorothy Hayden, a pathologist with Roche Diagnostics, provides a guided digital review of non-small cell lung carcinoma (NSCLC) specimens stained with the Ventana…
-
0 likes 168 playsDr. Dorothy Hayden, a pathologist with Roche Diagnostics, provides instruction on evaluating the Ventana PD-L1 (SP263) assay in non-small cell lung carcinoma (NSCLC)…
-
0 likes 276 playsDr. Dorothy Hayden, a pathologist with Roche Diagnostics, provides a brief overview of the Ventana PD-L1 (SP263) assay & staining in non-small cell lung carcinoma…
-
1 likes 50 playsDr. Tom Wright is an internationally recognized expert who has been instrumental in key clinical trials driving the development of novel diagnostics in the field of…
-
1 likes 39 playsReview of FDA classification of IVD assays, overview of clinical trial process as well as IVD development including analytical validation. TE-US-01092
-
0 likes 23 playsReview of preanalytic variables in immunohistochemical assay staining. TE-US-01089
-
0 likes 12 playsValidation approach for low prevalence biomarkers and biomarkers in rare diseases for IHC assays. TE-US-01072
-
0 likes 14 playsShort video on implementing IHC assays in the anatomic pathology laboratory. TE-US-01071
-
1 likes 25 playsAn overview of validation and verification of IHC in vitro diagnostic assays. TE-US-00990
-
0 likes 7 playsDr. Bharathi Vennapusa reviews CAP/ASCO 2020 guideline update for ER/PgR testing in breast cancer and how these guidelines pertain to Roche ER/PgR assays.
-
0 likes 36 playsDr. Beatrice Wegrzyniak of Roche medical and scientific affairs provides an overview of interpretation of the CINtec PLUS Cytology Assay for cervical cancer triage. …
-
1 likes 36 playsDr. Beatrice Wegrzyniak of Roche medical and scientific affairs team discusses the biomarkers that indicate cell cycle deregulation in cervical cancer screening. Part…
-
1 likes 42 playsDr. Linda Ahn from Roche Medical and Scientific Affairs team provides an introduction to the IMPACT trial data for use of biomarkers in cervical cancer triage. Part 2…
-
1 likes 15 playsDrs. Bharathi Vennapusa, Denise Croix and Katie Robertson discuss overview of NTRK fusions, testing methods, algorithms with a focus on pan-TRK IHC assay using VENTANA…
-
0 likes 16 playsIn this short video, Roche Pathologist, Michael Lynch, M.D. reviews the scoring method for the VENTANA HER2 Dual ISH assay as well as discusses scoring challenges and…